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Introduction {#sec1}
============

RNA viruses represent a threat to global public health, and this has been confirmed time and time again over the past 20 years. During this period, the world has witnessed outbreaks of West Nile virus, severe acute respiratory syndrome coronavirus, chikungunya virus, Middle East respiratory syndrome coronavirus, and currently Zika virus. These events highlight our inability to predict the next outbreak as well as our inability to treat or prevent infections once the outbreak is underway ([@bib7], [@bib42]). Antiviral therapeutics with broad-spectrum activity would greatly improve our readiness for the inevitable outbreaks of the future, but such therapeutics are few, at best.

All RNA viruses encode an RNA-dependent RNA polymerase (RdRp) to produce viral mRNA and progeny genomes ([@bib43]). While the mechanisms for initiation can vary ([@bib43]), once initiated, all RdRps transfer a ribonucleotide, selected in a template-dependent manner, to the 3′ end of a primer. Consistent with this conserved mechanism is the conserved nature of the RdRp active site ([@bib43]). This conservation makes the viral RdRp a very attractive target for developing broad-spectrum antiviral therapeutics. Indeed, ribavirin, a nucleoside analog, is one of the few antiviral therapeutics with broad-spectrum activity. For more than 30 years, however, the mechanism of action was thought to be inhibition of a cellular enzyme involved in purine nucleotide biosynthesis ([@bib51]), while it is now known that the antiviral activity is mediated by the RdRp in the case of poliovirus (PV) and likely other RNA viruses ([@bib14], [@bib15]).

Since the mechanism of ribavirin action was discovered, efforts to develop antiviral nucleosides against myriad RNA viruses have ensued ([@bib23]). To date, antiviral nucleosides fall into three categories: mutagen, obligate chain terminators, and non-obligate chain terminators. Ribavirin is an example of a mutagen because its triazole carboxamide pseudobase can hydrogen bond to both uracil and cytosine, leading to ambiguous incorporation ([@bib14]). Cordycepin is the classic obligate chain terminator. This adenosine analog contains a 3′-deoxyribose, thus precluding extension once incorporated ([@bib39]). Non-obligate chain terminators produced to date have a natural base and a 3′-hydroxyl moiety on the sugar but have a substituent appended to the ribose ring that interferes with a post-incorporation translocation event by some still-unknown mechanism ([@bib12], [@bib49]). Among the first member of this class is the 2′-C-methyl substituent ([@bib12]). This substituent is a critical component of the anti-hepatitis C virus drug sofosbuvir ([@bib49]).

Recently, a new class of antiviral base/ribonucleoside has been approved for use in the treatment of influenza virus infection ([@bib29]). These drugs contain a pyrazine-carboxamide pseudobase, which is similar to the pseudobase of ribavirin in that both contain a rotationally mobile carboxamide moiety as a determinant for base-pairing. The approved drug is just the pseudobase and has been named favipiravir (also known as T-705). Favipiravir and a related nucleoside, T-1106, exhibit broad-spectrum activity ([@bib29]). However, the mechanism of action of this class of antiviral agents is unclear. Some have suggested that it is a non-obligate chain terminator ([@bib45]), others have suggested that it is a mutagen ([@bib17], [@bib18]), and others have suggested that it is both a non-obligate chain terminator and a mutagen ([@bib33]).

The inability to define the mechanism of action of favipiravir reflects the lack of tools available to study nucleic acid polymerases and their inhibitors. Experiments employing long templates that reveal inhibition cannot distinguish among nucleotide competition, decreased elongation efficiency, and chain termination ([@bib33]). Experiments employing short templates that reveal specificity and efficiency of addition do not offer varied sequence context that could be essential to observe perturbed elongation efficiency or even chain termination ([@bib45]). We have recently developed a multiplexed magnetic tweezers apparatus in which hundreds of magnetic beads are tethered to a flow chamber surface by individual double-stranded RNA (dsRNA) molecules ([@bib13], [@bib24], [@bib26], [@bib8]), all of which experience the same force ([@bib54], [@bib19]). This high-throughput instrument enables probing of rare events that interrupt polymerase kinetics (e.g., error or nucleotide analog incorporation). This approach was established using the RdRp from bacteriophage Φ6 RdRp ([@bib26]), where we followed the activity of tens of polymerases on RNA templates thousands of nucleotides in length and provided sufficient statistics to quantitatively examine nucleotide (analog) incorporation in the presence of all four natural nucleotides. This provides the ability to assess not only the consequences of nucleotide analog incorporation but also its mechanistic basis.

The RdRp from PV is the most extensively characterized human RNA virus polymerase known ([@bib10]) and was used to elucidate the mechanism of action of ribavirin ([@bib14]). Here, we apply our high-throughput magnetic tweezers approach to the PV RdRp with the goal of obtaining insight into the mechanism of action of the pyrazine-carboxamide class of antiviral therapeutics. The basic mechanics of nucleotide-addition observed for the Φ6 RdRp is consistent with our PV RdRp data. We exploited the existence of a mutator PV RdRp to prove the existence of a low-fidelity elongation complex and examine its dynamics. While prokaryotic and nuclear RNA polymerases have a tendency to backtrack when forward motion is obstructed (e.g., by binding of inhibitors), incorporation of neither class of chain terminator induced backtracking. In contrast, incorporation of a pyrazine-carboxamide nucleotide caused backtracking of the PV RdRp, an event from which the enzyme was able to recover given sufficient time. Ensemble experiments showed that this backtracking behavior manifests as inhibition and that incorporation exhibited a very relaxed template specificity. Studies in cells were consistent with this unique mechanism of action, as PV mutants exhibiting enhanced or diminished sensitivity to mutagens and chain terminators did not exhibit a corresponding change in sensitivity to the pyrazine-carboxamide nucleotide. We conclude that the active pyrazine-carboxamide nucleoside triphosphate metabolite defines a distinct mechanistic class of antiviral (deoxy)ribonucleotides.

Results {#sec2}
=======

Interpreting Pauses of Polymerase Activity Observed in High-Throughput Magnetic Tweezers Experiments Using PV RdRp and a Mutator Derivative {#sec2.1}
-------------------------------------------------------------------------------------------------------------------------------------------

Since the elucidation of the first kinetic mechanism for a nucleic acid polymerase nearly 30 years ago ([@bib36], [@bib37]), the approaches used to interrogate the kinetics, mechanism, and fidelity of nucleic acid polymerases have remained essentially the same. A single cycle of nucleotide addition is monitored. When processive incorporation is monitored, quantitative analysis is only possible when measuring ten or fewer incorporation events. How ensemble measurements made on a short primed template, and corresponding inferences, inform the real-world scenario in which thousands or even millions of incorporation events must occur remains to be determined. Here, we study polymerase kinetics by monitoring elongation for thousands of nucleotide-incorporation events with near-single-nucleotide resolution in relative position. (As absolute position is established at lower resolution, we do not report on the sequence context.) The initial study employing this method used the RdRp from bacteriophage Φ6, an enzyme for which extensive kinetic data and corresponding mechanistic models had been lacking ([@bib26]).

Much of what is known about the kinetics, mechanism, and fidelity of viral RdRps has been learned from studies of picornaviral RdRps, in particular PV RdRp ([@bib10]). The PV enzyme therefore permits comparisons between the magnetic tweezers experiment and classical approaches. In addition, PV RdRp derivatives exist to permit kinetic and mechanistic parameters determined by using the magnetic tweezers experiment to be correlated to rate and equilibrium constants obtained by using classical approaches. The experimental design is shown in [Figure 1](#fig1){ref-type="fig"} . Following successful initiation on a short hairpin located at the 3′ end of the template strand of the dsRNA tether, RNA synthesis by PV RdRp displaces the templating strand from the tethering strand, lengthening the bead-tethered RNA because of its conversion from dsRNA to single-stranded RNA (ssRNA) ([Figure 1](#fig1){ref-type="fig"}A) ([@bib26]). Single, elongating molecules of PV RdRp examined in high-throughput mode ([Figure S1](#mmc1){ref-type="supplementary-material"}A) exhibited stochastic dynamics in which bursts of nucleotide addition were interrupted by pauses lasting \<10 s ([Figure 1](#fig1){ref-type="fig"}B). From these time courses, we first extract coarse-grained information pertaining to the processivity of PV RdRp on the dsRNA template. The median processivity was found to equal 1,390 ± 160 bp ([Figure 1](#fig1){ref-type="fig"}C; unless mentioned otherwise, see [Experimental Procedures](#sec4){ref-type="sec"} for descriptions of error determination) at a saturating concentration of nucleotide triphosphates (NTPs; 1 mM of each NTP). Second, we collect more fine-grained information that allows us to extract mechanistic insight from the dataset by recording the dwell times of PV RdRp in consecutive windows of 5-nt-addition cycles ([@bib24], [@bib26]).Figure 1Characterizing PV RdRp Activity Using High-Throughput Magnetic Tweezers(A) Schematic of the experimental assay to monitor RNA synthesis. *F* represents the constant force applied to the (predominantly) dsRNA tether. Apart from a short hairpin to the 3′ end of the 2.8-kb template strand to enable primed initiation by PV RdR, the dsRNA tether is as described in [@bib26]. During RNA synthesis, the RdRp displaces the template strand from the tethering strand, increasing the end-to-end distance of the magnetic bead from the coverslip surface.(B) 40 time courses of individual RdRp-elongation complexes acquired in a single experiment at 30 pN applied force and 100 μM NTP concentration. The traces are acquired at an acquisition frequency of 25 Hz and are subsequently low-pass filtered at 0.5 Hz and synchronized, resulting in the representation shown. Collectively, these traces illustrate the variation in the dynamics and processivity of PV RdRp, with the leftmost traces including almost no pauses and the rightmost traces including many short pauses.(C) Histogram of the processivity of 77 PV RdRps under the conditions described in (B).(D) The dwell-time distribution is extracted from 77 time courses of RNA synthesis by PV RdRp acquired at 30 pN applied force and 100 μM NTP concentration. The red circles represent all the data, whereas the black circles represent the data that remain after filtering out the shortest and longest dwell times (0.05% of the total data collected). We fit this distribution to a stochastic-pausing model ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) using MLE (dashed black line). For clarity, we individually plot each contribution to the dwell-time distribution: the gamma distribution (green), the first short pause (pause 1; dark blue), and the second short pause (pause 2; light blue). Error bars are determined as described in [Experimental Procedures](#sec4){ref-type="sec"}.

We fit a general stochastic-pausing model to the data using maximum-likelihood estimation (MLE) ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C; [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) and illustrate the results by showing empirical dwell-time distributions together with the fits ([Figure 1](#fig1){ref-type="fig"}D). Three distinct kinetic behaviors were observed in the dwell-time analysis: a fast phase of sub-second duration and two slow phases of durations ∼1 s (termed pause 1) and ∼5 s (termed pause 2) ([Figure 1](#fig1){ref-type="fig"}D). The component of the distribution in the time regime less than 1 s is dominated by polymerases synthesizing RNA through the dwell-time window without pausing. In the absence of noise, we expect this portion of the curve to be described by a gamma distribution of an order equal to the number of nucleotides in a dwell-time window (5 nt in this case). Our fits do not consistently yield a number of sub-steps agreeing with the 5-nt dwell-time window; this suggests that noise influences the short dwell times, preventing us from reporting the nucleotide addition rate. For longer dwell times, noise can be suppressed by filtering, and we can determine the fraction of dwell times where RNA synthesis was momentarily paused. We can extract several useful parameters relating to the pause dynamics: the apparent pause exit rates of pauses 1 and 2 ($k_{1}$ and $k_{2}$, respectively) and the pause probabilities ($P_{1}$ and $P_{2}$, respectively). At saturating nucleotide concentrations (100 μM per NTP), we find that elongating polymerases enter the fast phase with a probability of 83.0% ([Figure 1](#fig1){ref-type="fig"}D; calculated using the integral under the green solid line as detailed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}), enter pause 1 with a probability $P_{1}$ of 16.7% ([Figure 1](#fig1){ref-type="fig"}D; calculated using the integral under the dark blue solid line), and enter pause 2 with a probability $P_{2}$ of 0.3% ([Figure 1](#fig1){ref-type="fig"}D; calculated using the integral under the light blue solid line).

To obtain a baseline understanding of PV dynamics, we examine the nucleotide concentration dependence of the overall processivity and the dwell-time distributions. As expected, values of the median processivity decrease with decreasing nucleotide concentration ([Figure 2](#fig2){ref-type="fig"} A). The largest effect of decreasing nucleotide concentration on the dwell-time distribution is observed in the time regime greater than 10 s ([Figure 2](#fig2){ref-type="fig"}B). Pause exit rate $k_{1}$ is directly correlated with nucleotide concentration, ranging from 0.9/s to 0.06/s ([Figure 2](#fig2){ref-type="fig"}C, dark blue points). Probability $P_{1}$ is inversely correlated with nucleotide concentration, ranging from 17% to 41% ([Figure 2](#fig2){ref-type="fig"}D, dark blue points). Pause exit rate $k_{2}$ also correlated directly with nucleotide concentration, ranging from 0.2/s to 0.02/s. ([Figure 2](#fig2){ref-type="fig"}C, light blue points). Probability $P_{2}$ also correlated inversely with nucleotide concentration, ranging from 0.3% to 5% ([Figure 2](#fig2){ref-type="fig"}D, light blue points). As the probability of PV RdRp to engage in only nucleotide addition equals one minus the sum of $P_{1}$ and $P_{2}$, this approximates unity at saturating concentrations.Figure 2Influence of Nucleotide Concentration on the Pausing Behavior of PV RdRp(A) Median processivity of PV RdRp at 30 pN applied force for different concentrations of NTPs in the reaction.(B) The dwell-time distributions (circles) of PV RdRp activity at 30 pN applied force and 1 mM (red), 500 μM (orange), 100 μM (light orange), 10 μM (cyan), 1 μM (blue), and 0.1 μM (dark blue) nucleotide concentrations. The solid lines are the MLE fits to a scenario where rapid elongation competes with two long-lived pause states, as illustrated in [Figure 3](#fig3){ref-type="fig"}G. The kinetic parameters extracted from these fits are shown in (C) and (D).(C) Exit rates out of pause 1 ($k_{1}$, dark blue) and pause 2 ($k_{2}$, light blue) as a function of NTP concentration. As the NTP concentration is decreased from 1 mM to 0.1 μM, $k_{1}$ decreases from $\left( {0.925 \pm 36\%\ \text{CI}_{0.006}^{0.006}} \right)\ \text{s}^{- 1}$ to $\left( {0.065 \pm 36\%\ \text{CI}_{0.001}^{0.001}} \right)\ \text{s}^{- 1}$ and $k_{2}$ decreases from $\left( {0.237 \pm 36\%\ \text{CI}_{0.008}^{0.008}} \right)\ \text{s}^{- 1}$ to $\left( {0.021 \pm 36\%\ \text{CI}_{0.001}^{0.001}} \right)\ \text{s}^{- 1}$.(D) Probabilities of finding PV RdRp in pause 1 ($P_{1}$, dark blue) or pause 2 ($P_{2}$, light blue) as a function of NTP concentration. As the NTP concentration is decreased from 1 mM to 0.1 μM, $P_{1}$ increases from $0.167 \pm SD_{0.002}^{0.002}$ to $0.411 \pm 36\%\ \text{CI}_{0.005}^{0.007}$ and $P_{2}$ increases from $0.0033 \pm 36\%\ \text{CI}_{0.0002}^{0.0003}$ to $0.052 \pm 36\%\ \text{CI}_{0.003}^{0.004}$.In all panels, error bars are determined as described in [Experimental Procedures](#sec4){ref-type="sec"}.

Since pause 1 is quite probable, we cannot rule out that the fitted exit rate simply inherits its dependence on nucleotide concentration ([Figure 2](#fig2){ref-type="fig"}C) from the facts that repeated entries into the pause would extend its apparent lifetime and the probability of repeated entry is determined through a kinetic competition between the pause entry rate and a nucleotide-dependent catalytic step. Since pause 2 will only have been entered multiple times for a few percent of the scored long pauses ([Figure 2](#fig2){ref-type="fig"}D), repeated pause entry cannot affect the order of magnitude change seen in the exit rate of pause 2 ([Figure 2](#fig2){ref-type="fig"}C).

We consider whether nucleotide misincorporation by PV underlies the observed pausing behavior. Misincorporation of nucleotides by PV RdRp in vitro and in cells occurs at a frequency no greater than 0.0001 per nucleotide-incorporation event at rates much less than 0.1/s ([@bib3]). Therefore, it is impossible to conclude that pause 1 is the result of misincorporation. A state capable of correct nucleotide incorporation, but with low efficiency, is most probable. If pause 2 is a signature of nucleotide misincorporation ([@bib26]), then one must account for the higher frequency and rate observed here relative to classical methods ([@bib3]). However, such methods generally only evaluate utilization of a single, incorrect nucleotide ([@bib3]), and the experimental configuration employed differs in the use of a dsRNA template under applied force. To explore the potential impact of these differences, we examined the dependence of PV kinetics on applied force ([Figure S2](#mmc1){ref-type="supplementary-material"}A). When the applied force is lowered, the exit rates $k_{1}$ and $k_{2}$ both decrease by a factor of ∼2 ([Figure S2](#mmc1){ref-type="supplementary-material"}B, dark blue and light blue points), showing that our experimental configuration impacts the measured rates. However, the probabilities to enter each state are maintained constant over the experimentally accessible force range ([Figure S2](#mmc1){ref-type="supplementary-material"}C, dark and light blue points).

To rule in or rule out nucleotide misincorporation as a contributor to pause 1 and/or pause 2, we exploited the existence of a PV derivative with a mutator phenotype ([@bib35]). The H273R PV RdRp increases the frequency of all types of mutations by relaxing one of the fidelity checkpoints used by PV RdRp ([@bib35]). When examined at the single-molecule level, H273R PV RdRp exhibited a processivity of $\left( {1,081 \pm 125} \right)$ bp ([Figure 3](#fig3){ref-type="fig"} A), unaltered within experimental error compared to wild-type (WT) PV RdRp. We also examined the corresponding dwell-time distributions ([Figure 3](#fig3){ref-type="fig"}B), reasoning that an increased pause probability would be observed if the pause reflected, even in part, nucleotide misincorporation. When the H273R PV RdRp derivative was employed, it appeared that the parameters related to pause 1 ([Figures 3](#fig3){ref-type="fig"}C and 3D) do not change relative to WT. The probability $P_{2}$ increased by ∼6.3-fold ([Figure 3](#fig3){ref-type="fig"}F); a 3- to 5-fold increase in mutation frequency was observed for H273R PV RdRp using classical methods and in cells ([@bib35]). The exit rate $k_{2}$ increased by ∼50% ([Figure 3](#fig3){ref-type="fig"}E); a 20-fold increase in G:U mispair extension is observed for H273R PV RdRp using classical methods ([@bib41]). These observations with H273R PV RdRp point to nucleotide misincorporation as the origin of pause 2 during the elongation reaction observed in the magnetic tweezers experiments. If this is the case, then the magnetic tweezers data suggest that the frequency of mutation may be underestimated by classical methods, perhaps a reflection of evaluating one nucleotide at a time (see probability at concentrations ≥100 μM in [Figure 2](#fig2){ref-type="fig"}D). In addition, the magnetic tweezers data reveal a higher probability of misincorporation at lower nucleotide concentration (see probability at concentrations ≤100 μM in [Figure 2](#fig2){ref-type="fig"}D). Based on these findings, we construct a working kinetic model for elongation by PV RdRp that invokes a high-efficiency state favoring nucleotide addition and two paused states, of which at least the longest-lived state is elongation competent, albeit error-prone ([Figure 3](#fig3){ref-type="fig"}G; [Discussion](#sec3){ref-type="sec"}).Figure 3A Mutator PV RdRp (H273R) Displays Altered Pausing Behavior(A) Histogram of the processivities of H273R PV RdRp at 30 pN applied force and 100 μM NTP concentration.(B) Dwell-time distribution for H273R PV RdRp (gray) compared to WT PV RdRp (black). The solid lines are the MLE fits to a scenario where rapid elongation competes with two long-lived pause states, as illustrated in (G). The kinetic parameters extracted from these fits are shown in (C)--(F).(C) Exit rate $k_{1}$ for H273R PV RdRp (gray) compared to WT PV RdRp (white rectangle with black border). (D) Probability $P_{1}$ for H273R (gray) compared to WT (white rectangle with black border).(E) Exit rate $k_{2}$ for H273R PV RdRp (gray, $\left( {0.28 \pm 36\%\ \text{CI}_{0.02}^{0.02}} \right)\ \text{s}^{- 1}$) compared to WT PV RdRp (white rectangle with black border, $\left( {0.019 \pm 36\%\ \text{CI}_{0.009}^{0.009}} \right)\ \text{s}^{- 1}$).(F) Probability $P_{2}$ for H273R (gray, $0.0094 \pm 36\%\ \text{CI}_{0.0013}^{0.0011}$) compared to WT (white rectangle with black border, $0.0015 \pm 36\%\ \text{CI}_{0.0001}^{0.0001}$).(G) Schematic illustration of the kinetic pathway proposed to underlie elongation by PV RdRp. In this model, the incorporation of nucleotides can occur via one of several catalytically competent pathways. (Center, green) a principal pathway emanating from a high-efficiency catalytic (HEC) state in which PV RdRp adds nucleotides at a high rate with high fidelity. Presence in the HEC state is associated with bursts of nucleotide addition. (Top, dark blue) A second pathway emanating from a low-efficiency catalytic (LEC) state, in which PV RdRp adds nucleotides at a reduced rate. Presence in the LEC is associated with pause 1. The possibility that the fitted exit rate inherits its nucleotide dependence from repeated entry into pause 1 competing with a nucleotide-dependent catalytic step as shown in the center is indicated by the dashed arrow. (Bottom) A third pathway emanating from an error-prone, very low-efficiency catalytic (VLEC) state. Presence in the VLC is associated with pause 2.In (B)--(F), error bars are determined as described in [Experimental Procedures](#sec4){ref-type="sec"}.

Lessons on RdRp Misincorporation and Mismatch Bypass Learned from Magnetic Tweezers Experiments Performed Using Imbalanced Nucleotide Pools {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------------------

Classical methods studying polymerase error frequencies do so in the absence of other nucleotides. Our ability to link pause 2, at least in part, to nucleotide misincorporation provides a unique opportunity to study polymerase error frequencies in the presence of all four nucleotides. Here, we determine the impact of nucleotide-pool bias on the misincorporation frequency of PV RdRp and the extent to which a misincorporation event can be bypassed by the PV RdRp. In the control experiment, all four nucleotides were present at equimolar concentrations of 100 μM, for which we observed a median processivity of $\left( {1,197 \pm 89} \right)$ bp ([Figure 2](#fig2){ref-type="fig"}A) and a probability $P_{2}$ of $\left( {0.15 \pm 0.01} \right)$ % ([Figure 2](#fig2){ref-type="fig"}D). Subsequent experiments elevated the concentration of one of the four nucleotides by 10-fold to 1 mM ([Figure S3](#mmc1){ref-type="supplementary-material"}). We find no change in the median processivity when cytidine triphosphate (CTP) is in excess $\left( {1,199 \pm 60} \right)$ bp; [Figure S3](#mmc1){ref-type="supplementary-material"}A), whereas the presence of adenosine-, uridine-, or guanosine triphosphate (ATP, UTP, or GTP, respectively) in excess results in substantial decreases in the median processivity by ∼24%, ∼30%, and ∼45% to $\left( {913 \pm 44} \right)\ \text{bp}$, $\left( {835 \pm 64} \right)$ bp, and $\left( {656 \pm 65} \right)$ bp, respectively; [Figure S3](#mmc1){ref-type="supplementary-material"}A). Potentially, following misincorporation of cytidine monophosphate (CMP), PV RdRp is able to recover and continue elongation as before; conversely, following misincorporation of adenosine-, uridine-, or guanosine monophosphate (AMP, UMP, or GMP, respectively), PV RdRp may have more difficulty bypassing these mispairs, an increased tendency to stall, or an increased propensity to dissociate from the template. Analysis of the dwell-time distributions ([Figure S3](#mmc1){ref-type="supplementary-material"}B) shows that the parameters of pause 1 were slightly altered by an imbalanced nucleotide pool, with the value of $\text{k}_{1}$ being consistently lowered by 10%--40% for all NTPs with the exception of ATP ([Figure S3](#mmc1){ref-type="supplementary-material"}C) and a slight increase of probability $P_{1}$ under all conditions ([Figure S3](#mmc1){ref-type="supplementary-material"}D). The changes in probability $P_{2}$ were found to be more significant and ranged from no change for ATP or a moderate 2- to 3-fold change for UTP and GTP to a substantial 6-fold change for CTP ([Figure S3](#mmc1){ref-type="supplementary-material"}F). The frequency of each nucleotide in the template is essentially equal; therefore, these differences cannot be attributed to templating bias. The misincorporation events caused by the skewed nucleotide pool were not all bypassed equivalently; exit rate $k_{2}$ for GTP was significantly reduced ([Figure S3](#mmc1){ref-type="supplementary-material"}E).

Characterization of a Lethal Mutagen, Obligate Chain Terminator, and a Non-obligate Chain Terminator Using Magnetic Tweezers {#sec2.3}
----------------------------------------------------------------------------------------------------------------------------

We next characterize the dynamic response of PV RdRp to two nucleotide analogs known to be substrates for a variety of RdRps, including PV RdRp, inosine triphosphate (ITP), and ribavirin triphosphate (RTP) ([Figure 4](#fig4){ref-type="fig"} A). ITP is known to increase $P_{2}$ for bacteriophage Φ6 RdRp ([@bib26]), and RTP has been described as a mutagen because of its ability to template by both uridine and cytidine ([@bib14], [@bib15]). To assess how PV RdRp dynamics change in the presence of these nucleotide analogs, we compare experiments at saturating NTP concentrations (100 μM per NTP) to experiments at these NTP concentrations supplemented with 1 mM of either ITP or RTP). In the latter case, we observe that median values for processivity are not significantly affected ([Figure 4](#fig4){ref-type="fig"}B). The corresponding dwell-time distributions are shown in [Figure 4](#fig4){ref-type="fig"}C; analysis thereof shows that the parameters associated with pause 1 are slightly affected, with exit rate $k_{1}$ being lowered by 10%--40% for ITP and RTP ([Figure S4](#mmc1){ref-type="supplementary-material"}A) and a slight increase of probability $P_{1}$ ([Figure S4](#mmc1){ref-type="supplementary-material"}B). The presence of both ITP and RTP leads to increases in probability $P_{2}$ relative to standard conditions (3-fold for ITP and 2-fold for RTP; [Figure 4](#fig4){ref-type="fig"}D).Figure 4The Presence of Nucleotide Analogs Increases Misincorporation and Stalling by PV RdRp(A) Chemical structure of the different antiviral nucleoside triphosphate analogs tested.(B) Processivity at 100 μM NTPs (Ø) and supplemented with 1 mM RTP (R, purple) or 1 mM ITP (I, crimson).(C) The dwell-time distributions acquired at 30 pN applied force with 100 μM NTPs (black circles) supplemented with 1 mM RTP (purple circles) or 1 mM ITP (crimson circles). The solid lines are the MLE fits to a scenario where rapid elongation competes with two long-lived pause states, as illustrated in [Figure 3](#fig3){ref-type="fig"}G. The kinetic parameters extracted from these fits are shown in (D) and [Figure S4](#mmc1){ref-type="supplementary-material"}.(D) The probability of pause 2 under the conditions described in (B) and (C): $P_{2;\text{Ø}\ } = 0.0015 \pm 36\%\ \text{CI}_{0.0001}^{0.0001}$), $P_{2;\ 1\ mM\ RTP} = 0.0038 \pm 36\%\ \text{CI}_{0.0004}^{0.0004}$, and $P_{2;1\ mM\ ITP} = 0.0047 \pm 36\%\ \text{CI}_{0.0003}^{0.0006}$.(E) The median processivity of PV RdRp at 30 pN applied force and the standard concentration of 100 μM NTPs in the absence or presence of the indicated concentration of 3′-dATP.(F) The median processivity of PV RdRp at 30 pN applied force and the standard concentration of 100 μM NTPs in the absence or presence of the indicated concentration of 2′-C-Me-ATP.(G and H) The dwell-time distributions at 30 pN applied force in the presence of 100 μM NTPs (black circles) supplemented with 1 μM 3′-dATP (light green circles), 10 μM 3′-dATP (green circles), or 100 μM 3′-dATP (dark green circles) (G) or 1 μM 2′-C-Me-ATP (light blue circles), 5 μM 2′-C-Me-ATP (blue circles), and 50 μM 2′-C-Me-ATP (dark blue circles) (H). The solid lines are the MLE fits to a scenario where rapid elongation competes with two long-lived pause states, as illustrated in [Figure 3](#fig3){ref-type="fig"}G. The kinetic parameters extracted from these fits are shown in [Figure S4](#mmc1){ref-type="supplementary-material"}.(I) Probability of dwell times longer than 40 s as a function of 3′-dATP or 2′-C-Me-ATP concentration from the distributions presented in (G) and (H).In (B)--(I), error bars are determined as described in [Experimental Procedures](#sec4){ref-type="sec"}.

To extend our study of the effect of nucleotide analogs on PV RdRp, we also characterize two ATP analogs that act as chain terminators, namely the obligate terminator 3′-deoxyadenosine-TP (3′-dATP)([@bib5]) and the non-obligate terminator 2′-C-methyl-adenosine-TP (2′-C-Me-ATP) ([@bib12]) ([Figure 4](#fig4){ref-type="fig"}A). 3′-dATP terminates RNA extension because of the absence of a 3′-OH to serve as the nucleophile during the next cycle of nucleotide addition ([@bib50]). For 2′-C-Me-ATP, the reason for termination is unknown. One suggestion is that a methyl group above the ribose ring may hinder translocation ([@bib11]). To test the effect of these chain terminators, we supplement our standard NTP concentration with 1, 10, and 100 μM 3′-dATP or 1, 5, and 50 μM 2′-C-Me-ATP, respectively. Under these conditions, both terminators compete with the 100 μM ATP present in the reaction buffer. When the concentrations of 3′-dATP or 2′-C-Me-ATP are increased, we observe the median values of the processivity to consistently decrease, reaching minimum values of $\left( {397 \pm 18} \right)$ bp for 100 μM 3′-dATP and $\left( {585 \pm 38} \right)$ bp for 50 μM 2′-C-Me-ATP ([Figures 4](#fig4){ref-type="fig"}E and 4F). While these observations are consistent with the proposed mode of action of these terminators ([@bib5]), they also suggest that these nucleotide analogs compete relatively poorly with ATP for incorporation; a median value for processivity of ∼400 bp in the presence of 100 μM 3′-dATP is expected, taking into account the uracil content of our template, to correspond to the incorporation of ∼100 ATP prior to termination. Similarly, ensemble experiments show a 17-fold higher selectivity $\left( {k_{pol}/K_{d,app}} \right)$ for correct ATP than for 3′-dATP ([@bib5]).

The dwell-time distributions ([Figures 4](#fig4){ref-type="fig"}G and 4H) of PV RdRp in the presence of chain terminators do not show any difference on short timescales (\<10 s), indicating that the pauses 1 and 2 are unperturbed by 3′-dATP or 2′-C-Me-ATP ([Figures S4](#mmc1){ref-type="supplementary-material"}E--S4H and [Figures S4](#mmc1){ref-type="supplementary-material"}I--S4L, respectively). However, examination of the dwell-time distributions on longer timescales reveals the existence of a new type of long pause (\>40 s; [Figures 4](#fig4){ref-type="fig"}G and 4H) in the presence of both 3′-dATP (at 10 and 100 μM; [Figure 4](#fig4){ref-type="fig"}I, green points) and 2′-C-Me-ATP ([Figure 4](#fig4){ref-type="fig"}I, blue points). While these long pauses may affect the fit parameters used to characterize pause 2 kinetics, they are clearly separate from the pause 2 distribution.

Pyrazine-Carboxamide Nucleotide Induces Polymerase Backtracking, Defining a Distinct Mechanistic Class of Antiviral Nucleotide {#sec2.4}
------------------------------------------------------------------------------------------------------------------------------

To illustrate the utility of the molecular tweezers approach in providing insight into the mechanism of action of an antiviral nucleotide, we chose to study a member of the pyrazine-carboxamide family. The best-known member of this family is T-705, which has been approved for treatment of influenza virus infection, but its mechanism of action is actively debated ([@bib29]). Here, we studied T-1106, which is closely related to T-705, but its nucleosides and nucleotides are more synthetically tractable ([Figure 5](#fig5){ref-type="fig"} A). Because there is no mechanistic information for this class of antiviral nucleotide with PV RdRp, we first evaluated the specificity and efficiency of T-1106-TP utilization using our standard, bulk biochemical assays ([@bib3]). PV RdRp incorporates T-1106-MP opposite uridine, adenosine, or cytidine in the template, but not opposite guanosine ([Figures 5](#fig5){ref-type="fig"}B and 5C). As a control, we show that PV RdRp incorporates RMP opposite uridine and cytidine, as shown previously ([@bib14]). PV RdRp efficiently bypasses T-1106:C pair, but the enzyme stalls at a T-1106:A pair (strong band at line $\text{n} + 3$; [Figure 5](#fig5){ref-type="fig"}D). The stalling occurs for durations as long as 300 s. PV RdRp exhibits a context dependence for T-1106-MP incorporation opposite uridine, ranging from very inefficient ([Figure 5](#fig5){ref-type="fig"}D) to quite efficient ([Figure 5](#fig5){ref-type="fig"}E). The context dependence for incorporation and/or bypass also extends to T-1106:A pairs ([Figures 5](#fig5){ref-type="fig"}E and 5F). These experiments suggest that incorporation of T-1106-MP opposite adenosine creates an impediment to RNA synthesis. Interestingly, when T-1106-MP is in the RNA template, PV RdRp only incorporates UMP or CMP ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5D). Only a fraction of elongation complexes are competent for efficient incorporation and bypass opposite T-1106-MP ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5D). Thus, from these bulk biochemical experiments, we conclude that incorporation of T-1106-MP by PV RdRp opposite adenosine substantially reduces the nucleotide-addition rate of subsequent nucleotides (on timescales from tens to hundreds of seconds; [Figure 5](#fig5){ref-type="fig"}G), and its presence in the template strand hinders nucleotide addition. PV RdRp exhibits the same properties described above when using T-705-TP ([Figure S6](#mmc1){ref-type="supplementary-material"}). These observations are consistent with studies in other viral systems, suggesting that pyrazine-carboxamide analogs are chain terminators ([@bib45], [@bib33]).Figure 5Ambiguous Templating of a Pyrazine-Carboxamide Nucleotide Analog, T-1106-TP, Induces Context-Dependent Stalling of PV RdRp(A) Chemical structure of T-1106-triphosphate (T-1106-TP).(B and C) The symmetrical primed templates employed are referred to as sym/sub-UACG (B) or sym/sub-CGAU (C). The first and subsequent templating bases are underlined. PV RdRp incorporates T-1106-MP opposite uridine, adenosine, or cytidine, but not guanosine. For comparison, the utilization of RTP and the first correct NTP substrate (ATP or GTP) are shown as controls. Each reaction was quenched after 60 s.(D--F) The elongation reaction products from PV RdRp-catalyzed T-1106-MP incorporation in the presence of additional correct nucleotide substrates. Reactions contained the indicated symmetrical primed templates and nucleotides. The incorporation of T-1106-MP opposite adenosine (A:T-1106-MP) (D) results in the production of terminated products or in a substantial reduction in the efficiency of utilization of the next correct nucleotide substrate. Comparable delays are not observed for incorporation opposite cytidine (C:T-1106-MP) or uridine (U:T-1106-MP) (E). (F) Stalling occurs opposite adenosine at n + 2.(G) Kinetics of RNA synthesis for the reaction products (n + 1, n + 2, and n + 3) shown in (F). Incorporation of T-1106-MP opposite adenosine at n+2 slows down the rate of utilization of the next correct nucleotide substrate (GTP, n+3) consistent with the presence of a stalled polymerase.

We now determine the impact of T-1106-TP utilization on the elongation dynamics of PV RdRp in the presence of standard NTP concentrations using the magnetic tweezers platform. From the time courses, it is immediately evident the presence of T-1106-TP causes the appearance of previously unobserved long pauses (\>20 s; [Figure 6](#fig6){ref-type="fig"} A; compare to [Figure 1](#fig1){ref-type="fig"}B), even at low concentrations of T-1106-TP (1 μM). Following such pauses induced by T-1106-TP, PV RdRp resumes elongation; the apparent decrease in the median processivity to $\left( {366 \pm 23} \right)\ \text{bp}$ (at 100 μM T-1106-TP; [Figure 6](#fig6){ref-type="fig"}B) results from temporal limits on the length of our data acquisitions. Based on these observations, we conclude that the effect of T-1106-MP incorporation is to stall RdRp elongation for long periods of time, but not to terminate elongation. Zooming in on the corresponding traces, we observe that several of them show significant extension decreases ([Figure 6](#fig6){ref-type="fig"}C) that likely correspond to backtracking by PV RdRp. In addition, the lifetime of this new pause appears distributed in a way consistent with backtracking, in contrast to the pause introduced by chain terminators (compare [Figure 6](#fig6){ref-type="fig"}D to [Figures 4](#fig4){ref-type="fig"}H and 4I). Backtracking has previously been reported for Φ6 P2 RdRp ([@bib27]) and for multi-subunit RNA polymerases ([@bib30], [@bib47]). We include the contribution from backtracked pauses in our model ([@bib21], [@bib26], [@bib27]), but as we cannot extract the position of shoulder corresponding to the basic hopping rate in the backtrack ([@bib21]) from under the distribution of pause 1 and pause 2, we cannot deduce the total fraction of backtracking events. However, since the basic hopping rate is unlikely to depend on T-1106-TP concentration, we can still determine the relative change in the probability to enter a backtrack as the T-1106-TP concentration is varied ([Figure 6](#fig6){ref-type="fig"}E). In the absence of T-1106-TP, we find no evidence of backtracking in the dwell-time distributions.Figure 6T-1106-TP Induces Backtracking of PV RdRp(A) Sixteen time courses of RNA synthesis acquired at 30 pN applied force and the standard concentration of 100 μM NTPs supplemented with 100 μM of T-1106-TP. These time courses are acquired at an acquisition frequency of 25 Hz.(B) Processivity of PV RdRp in the absence of T-1106 (white with black border) and in the presence of 1 μM (light yellow), 10 μM (light orange), or 100 μM (dark orange) T-1106-TP.(C) A zoom-in onto a single time course illustrating a decrease in the length of the RNA tether, corresponding to the rehybrization of ∼20 nt, followed by a long pause prior to resumption of elongation. This phenomenon is consistent with backtracking. The time course acquired at 25 Hz is shown in turquoise and, following low-pass filtering at 0.5 Hz, in black.(D) Dwell-time distributions assembled from the PV RdRp time courses acquired at 30 pN applied force with 100 μM NTPs (black circles) complemented with 1 μM T-1106TP (yellow circles), 10 μM T-1106TP (light orange circles), or 100 μM T-1106-TP (dark orange circles). The solid lines are the MLE fits to a scenario where rapid elongation competes with two long-lived pause states, as illustrated in [Figure 3](#fig3){ref-type="fig"}G, and extended to include a backtracked state in the presence of T-1106-TP as described in [@bib26]. The kinetic parameters extracted from these fits are shown in (E) and [Figure S7](#mmc1){ref-type="supplementary-material"}.(E) The relative probability of finding PV RdRp in the backtracked state (as deduced from the fits in D) in the presence of 1 μM (light yellow), 10 μM (light orange), or 100 μM (orange) T-1106-TP.In (B), (D), and (E), error bars are determined as described in [Experimental Procedures](#sec4){ref-type="sec"}.

A Unique Mechanism of Action of T-1106 against PV in Cell Culture {#sec2.5}
-----------------------------------------------------------------

The biochemical studies suggest that primary cause of the inhibitory activity of T-1106 relates to the backtracking induced by T-1106-MP incorporation into viral RNA. We have described PV mutants exhibiting increased sensitivity (H273R PV) or decreased sensitivity (G64S PV) to ribavirin caused by decreased or increased fidelity of the encoded RdRp ([@bib4], [@bib35]). As shown in [Figure 7](#fig7){ref-type="fig"} A, plating virus in the presence of increasing concentrations of ribavirin yields a dose-dependent reduction in the yield of plaques. H273R PV is more sensitive to ribavirin than WT PV, and G64S PV is less sensitive to ribavirin than WT PV. In contrast, the response of the PV strains to T-1106 is identical ([Figure 7](#fig7){ref-type="fig"}B). This observation is consistent with an event post-incorporation causing the antiviral outcome of T-1106 (e.g., backtracking). Finally, we performed a direct comparison of the efficacy and toxicity of T-1106 to ribavirin as described in [Experimental Procedures](#sec4){ref-type="sec"}. The efficacy of both compounds is within twofold of each other (half maximal inhibitory concentration \[IC~50~\] in [Figure 7](#fig7){ref-type="fig"}C). However, T-1106 is fivefold less toxic to HeLa cells than ribavirin (50% cytotoxic concentration \[CC~50~\] in [Figure 7](#fig7){ref-type="fig"}C).Figure 7Unique Mechanism of Action of a Pyrazine-Carboxamide Nucleoside Analog Observed in Virus-Infected Cells(A and B) Inhibition of virus production by ribavirin (A) or T-1106 (B). We infected drug-treated cells with PV expressing WT, high-fidelity (G64S) RdRps, or low-fidelity (H273R) RdRps. Sensitivity to ribavirin correlates directly to RdRp fidelity, but sensitivity to T-1106 does not, consistent with a mechanism of action different from that of ribavirin. The solid lines represent the fit of the data to a sigmoidal dose-response equation (four-parameter logistic model). The IC~50~ values for ribavirin with WT, G64S, and H273R are 0.55 ± 0.03 m[M]{.smallcaps}, 2.05 ± 0.10 m[M]{.smallcaps}, and 0.062 ± 0.003 m[M,]{.smallcaps} respectively. The IC~50~ values for T-1106 with WT, G64S and H273R are 0.51 ± 0.03 m[M]{.smallcaps}, 0.49 ± 0.03 m[M]{.smallcaps}, and 0.35 ± 0.01 m[M,]{.smallcaps} respectively. Error bars represent ±SEM.(C) Anti-poliovirus activity (IC~50~) and HeLa cell toxicity (CC~50~) of T-1106 and ribavirin.

Discussion {#sec3}
==========

Nucleic acid polymerases can transcribe or replicate genomes with both speed and accuracy over thousands, millions, or even billions of nucleotide-addition cycles. For decades, experimental systems suitable for quantitative kinetic analysis of nucleotide addition have been capable of evaluating on the order of ten events, with emphasis often placed on one or two incorporation events ([@bib3], [@bib34]). When one or two incorporation events are monitored, only one or two NTPs are present in the reaction, which is an unnatural circumstance. Notwithstanding this limitation, the approach has yielded copious insight into polymerase mechanism and has helped to explain and predict myriad biological phenotypes ([@bib28], [@bib4], [@bib5], [@bib6], [@bib35], [@bib38]). Nevertheless, two questions remain: (1) how does incorporation of thousands of nucleotides compare to incorporation of a few, and (2) what new insights can be gleaned from monitoring many, many incorporation events?

This study reports the second use of our magnetic tweezers instrument, which was designed to simultaneously measure hundreds of polymerases performing thousands of cycles of nucleotide addition ([@bib13], [@bib24], [@bib26]), in the examination of RdRp kinetics. Our first study characterized the RdRp from bacteriophage Φ6 ([@bib26]), a system for which the initiation phase is well characterized ([@bib9], [@bib40], [@bib46], [@bib53]) but which lacks quantitative, kinetic, and thermodynamic information describing the behavior of the ensemble during elongation. We here alter that circumstance by studying the RdRp from PV, an enzyme for which substantial kinetic and thermodynamic data exist, as well as a deep understanding of the mechanisms governing enzyme speed and accuracy ([@bib10]). Studies of the Φ6 RdRp identified three apparently catalytic states and one non-catalytic, backtracked state of an elongating polymerase, and most of these states are also observed for PV RdRp ([Figure 1](#fig1){ref-type="fig"}D). Nucleotide addition from the state with the shortest lifetime accounts for high-fidelity nucleotide incorporation and can be captured by a gamma distribution ([Figure 1](#fig1){ref-type="fig"}D). Because our data-analysis pipeline is unreliable for events occurring at rates faster than ∼1 s^−1^ due to filtering, it is not possible to extract rate constants for nucleotide addition. However, high-efficiency incorporation clearly occurs at rates of 10 s^−1^ and above, comparable to ensemble measurements ([@bib3]). The population of dwell times greater than ∼50 s ([Figure 1](#fig1){ref-type="fig"}D) occurs at such a low probability that we consider it an insignificant pause species. In contrast, this population of dwell times was more prevalent for Φ6 RdRp, where it was shown to represent polymerases that have undergone backtracking ([@bib27]). The states bracketed in time by the high-efficiency state and backtracked state are referred to as pause 1 and pause 2 ([Figure 1](#fig1){ref-type="fig"}D). The nature of these states is discussed below.

Our data analysis shows that the probability of entering pause 1 stabilizes at ∼10% during each nucleotide addition step at nucleotide concentrations higher than 100 μM, while the probability of entering this state increases when reducing the nucleotide concentration ([Figure 2](#fig2){ref-type="fig"}D). Because of the low probability of formation of pause 1, observing this elongating species in typical quench-flow ensemble experiments is unlikely. The 1 s^−1^ rate constant is too fast to represent misincorporation by PV RdRp based on ensemble experiments ([@bib3]). As suggested in the Φ6 RdRp study, it is possible that pause 1 reflects incorporation of correct nucleotides by a low-efficiency catalytic state of the elongation complex ([@bib26]). Molecular dynamics simulations of a PV RdRp elongation complex reveal numerous possibilities for the low-efficiency catalytic state, all of which use residues conserved in the catalytic sites of all RdRps with a PV RdRp fold ([@bib41]). The catalytic site toggles between a nucleotide-binding-competent state and a nucleotide-binding-occluded state ([@bib41]). Two primary conformations exist for interaction of the enzyme with the nascent base pair ([@bib41]). The motif-B loop of the enzyme can adopt four conformations, each with a unique outcome on the stability of the nascent base pair ([@bib41]). PV RdRp derivatives with substitutions in these conserved motifs analyzed using the magnetic tweezers platform should facilitate connection of pause 1 to a structural state. The exit rate $k_{1}$ is on par with observed rates of mispair extension measured by ensemble experiments ([@bib41], [@bib31], [@bib48]), and hence one could postulate that pause 1 reflects extension past a terminal mismatch. However, below we present evidence that associates the longer-lived pause 2 with nucleotide misincorporation, rendering this interpretation of the data unlikely.

Pause 2 must represent misincorporation. Ensemble experiments show that this event occurs on a timescale of minutes at a frequency of 10^−4^ or less ([@bib3]). The single-molecule experiments predict a timescale of seconds ([Figure 2](#fig2){ref-type="fig"}C) and probabilities of 10^−2^ ([Figure 2](#fig2){ref-type="fig"}D), both of which are substantially higher than ensemble measurements. Before considering these quantitative differences, we wanted to ensure that pause 2 reported on misincorporation at least in part. To do this, we used a PV RdRp derivative known to exhibit an elevated frequency of misincorporation, H273R ([@bib35]). This derivative exhibits an increase in exit rate $k_{2}$ ([Figure 3](#fig3){ref-type="fig"}E) and probability $P_{2}$ ([Figure 3](#fig3){ref-type="fig"}F); its 4-fold increase in probability relative to WT matches the magnitude of the increase in observed rate constants for nucleotide misincorporation measured in bulk ([@bib41], [@bib35]). In terms of the absolute differences in rate constants, it is possible that, like pause 1, pause 2 represents a very low-efficiency catalytic state competent for correct nucleotide incorporation and reflecting nucleotide misincorporation. As suggested above, there are sufficient conformations of the PV RdRp catalytic site to make this plausible. These correct incorporation events would add to the complexity of the pause 2 exit rate and probability, but there is no doubt that a component of pause 2 derives from misincorporation. An alternative possibility for the differences in exit rate $k_{2}$ measured in the single-molecule experiment and $k_{pol}$ for misincorporation measured in bulk is that the single-molecule experiment measures the activity of the pause 2 conformational state and/or its attenuation of the next incorporation event, while the bulk experiment measures the composite rate of, first, formation of the pause 2 conformational state and, subsequently, misincorporation. Regardless of the precise mechanism, the data support the notion that particular states of Φ6 and PV RdRps exist that are competent for misincorporation and that binding of an incorrect nucleotide does not induce this conformation. Identification of this state kinetically motivates its identification structurally, as this conformation has myriad practical applications. Perturbing the kinetic partitioning between these states either chemically or genetically underpins strategies for antiviral therapy and viral attenuation, respectively.

The ability of pause 2 to report on misincorporation permits the analysis of misincorporation of nucleotides harboring natural nucleobases, synthetic bases, and/or modified ribose sugars, all in the presence of all four natural nucleotides. This attribute of our magnetic tweezers approach is unique among the single-molecule and ensemble approaches used to study polymerase fidelity and nucleotide analog utilization, including its consequences for nucleotide incorporation. The interruptions are likely termination events as the mean processivity declines for most nucleotides ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Imbalanced NTP pools decrease the probability of uninterrupted cycles of nucleotide addition, as probabilities $P_{1}$ and $P_{2}$ both increase ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3F). Probability $P_{2}$ is the most affected parameter, as expected for a parameter responsive to misincorporation ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Two outliers exist. Excessive ATP is well tolerated ([Figure S3](#mmc1){ref-type="supplementary-material"}F). A concentration of 1 mM ATP is lower than the cellular concentration of ATP; thus, the RdRp may have evolved a mechanism to diminish misincorporation of AMP. The ability to incorporate a nucleotide after AMP misincorporation is quite efficient ([Figure S3](#mmc1){ref-type="supplementary-material"}E), again suggesting that the RdRp may have evolved mechanisms to prevent this misincorporation event from having a significant effect on viral RNA synthesis. Levels of CTP in the cell are far below 1 mM, but CMP misincorporation occurs with the highest probability of all nucleotides analyzed ([Figure S3](#mmc1){ref-type="supplementary-material"}F), is easily bypassed ([Figure S3](#mmc1){ref-type="supplementary-material"}E), and has absolutely no impact on processivity ([Figure S3](#mmc1){ref-type="supplementary-material"}A). U-to-C transition mutations are the most frequent RdRp-dependent mutation observed in cells during PV infection ([@bib35]). Interestingly, C-to-U transition mutations are the most frequent RdRp-independent mutation in cells, suggested to be the result of a member of the APOBEC family of cytidine deaminases ([@bib35]). We speculate that the propensity to misincorporate CMP may help to mitigate the impact of cytidine deamination. Finally, GMP misincorporation ([Figure S3](#mmc1){ref-type="supplementary-material"}F) has the greatest negative impact on processivity ([Figure S3](#mmc1){ref-type="supplementary-material"}A), which is likely a reflection of the impediment GMP mispairs pose to RdRp bypass ([Figure S3](#mmc1){ref-type="supplementary-material"}E).

Ribonucleotide analogs represent a class of antiviral agent with the greatest potential for broad-spectrum activity ([@bib20]). Analogs like ribavirin function by increasing the apparent mutation frequency of the virus because of the ambiguous base-pairing capacity of its pseudobase ([@bib14]). Efficacy of this class of antiviral ribonucleotide requires multiple incorporation events. Our studies here show that magnetic tweezers can be used to study incorporation of this analog in the presence of other NTPs. Probability $P_{2}$ increases ([Figure 4](#fig4){ref-type="fig"}D) without any impact on median processivity ([Figure 4](#fig4){ref-type="fig"}B). As a result, ribonucleotide analogs with chain-terminating activity are favored. A single incorporation event per RNA is sufficient to render the RNA biologically useless. Compounds with a 3′-deoxyribose, for example, 3′-dATP, are obligate chain terminators because of the loss of the nucleophile for nucleotidyl transfer. Obligate chain terminators are often substrates for cellular polymerases, leading to substantial toxicity ([@bib5]). In contrast, non-obligate chain terminators, those that retain a 3′-hydroxyl but inhibit subsequent rounds of nucleotide addition as a result of substituents added to the ribose ring, can exhibit higher selectivity and therefore lower cytotoxicity ([@bib5]). One of the first non-obligate chain terminators developed was 2′-C-Me-ATP ([@bib12]). The magnetic tweezers experiment reveals quite nicely the negative impact of both of these analogs on the median processivity, consistent with the chain-termination activity of these compounds. While termination activity is easily monitored in bulk experiments, the magnetic tweezers experiment also revealed restart of a few percent of the *terminated* traces on a timescale greater than 40 s ([Figure 4](#fig4){ref-type="fig"}I). Excision of chain terminators has been reported for several viral RdRps, including the RdRp from hepatitis C virus ([@bib16], [@bib22], [@bib32]). Demonstration of excision in bulk experiments often requires a contrived experimental setup. The magnetic tweezers experiment reveals this outcome under normal experimental conditions.

Our ability to evaluate the above antiviral ribonucleotides to obtain new information on these compounds using the magnetic tweezers motivated us to investigate a class of antiviral ribonucleotides for which the mechanism of action was unclear. This class of compounds contains a pyrazine-carboxamide pseudobase; we use the T-1106 nucleotide for our studies ([Figure 5](#fig5){ref-type="fig"}A) ([@bib29]). T-1106 is a synthetically more tractable alternative to T-705, which is currently approved to treat influenza virus infection but exhibits activity against numerous viruses ([@bib29]). The debate in the literature about this class compound is whether it is a mutagen, like ribavirin, or a non-obligate chain terminator. The structure of the compound fails to support the latter, as there is absolutely no modification of the ribose. How does a base induce termination? Ensemble experiments with PV RdRp clearly reveal the mutagenic activity and reveal a context-dependent failure of elongation, the definition of chain termination using this assay format ([Figures 5](#fig5){ref-type="fig"}B--5G). The failure to extend occurs primarily when T-1106-MP is incorporated opposite A in the template ([Figures 5](#fig5){ref-type="fig"}D--5F). What the magnetic tweezers experiment reveals is that incorporation of T-1106-MP induces long pauses ([Figure 6](#fig6){ref-type="fig"}A). Close inspection of the traces shows reannealing of the displaced strand to the tethered RNA ([Figure 6](#fig6){ref-type="fig"}C), an event identical to the backtracking events observed for Φ6 RdRp. Furthermore, the distribution of the long dwell times is also consistent with a backtracking process ([@bib27], [@bib21]) upon T-1106 addition ([Figure 6](#fig6){ref-type="fig"}D). Backtracking of an RdRp elongation complex in response to incorporation of a nucleotide analog defines a distinct mechanistic class of antiviral ribonucleotide, thus providing an explanation for the controversy. Is backtracking the mechanism of action in a cellular context? To address this question, we used PV mutants that exhibited decreased (G64S) or increased (H273R) sensitivity to nucleotide analogs with mutagenic or chain-terminating activity ([Figure 7](#fig7){ref-type="fig"}A) ([@bib4], [@bib35]). The response of these strains to T-1106 does not resemble the response to ribavirin ([Figure 7](#fig7){ref-type="fig"}B), consistent with a unique mechanism of action. Galidesivir (BCX4430), a ribonucleoside with broad-spectrum antiviral activity, was recently described ([@bib52]). This analog has a modified glycosidic bond without any other changes to the ribose or adenine base and has been suggested to be a non-obligate chain terminator ([@bib52]). The backtracking activity of this drug should be evaluated in the future.

Although we use an RdRp here, our approach and conclusions likely apply to all classes of nucleic acid polymerases. Combining traditional ensemble approaches with the magnetic tweezers approach produces a comprehensive understanding of polymerase speed, accuracy, and inhibition. Measuring rate constants for nucleotide incorporation with confidence is best done one nucleotide at a time using chemical quench-flow or stopped-flow instrumentation. However, as we demonstrate here, insight into processivity, strand-displacement synthesis, and rare asynchronous events such as misincorporation and incorporation of nucleotide analogs in the presence of a pool of natural nucleotides, excision of chain terminators and backtracking by polymerase are all best described by using magnetic tweezers instrumentation with high-throughput capabilities. Our ability to unmask these steps of the PV RdRp nucleotide-addition cycle has revealed unique, nucleotide-specific signatures in the pause kinetics of the enzyme and the discovery that some analogs can result in extreme pauses by inducing backtracking of the enzyme. We concluded that RdRp backtracking represents a viable mechanism for antiviral therapy. Studies of the physical and structural basis of backtracking are warranted.

Experimental Procedures {#sec4}
=======================

Further details and an outline of resources used in this work can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

dsRNA Tethers {#sec4.1}
-------------

Each (predominantly) dsRNA molecule consists of a template strand for PV RdRp hybridized to a complementary tethering strand that is linked at its two extremities to the flow chamber and the beads, respectively ([@bib26]). Apart from a small hairpin that terminates the 3′ end of the template strand (sequence of the initial 24 bases of the template strand: 3′-[GGGGAGCUCCCC]{.ul}UUUUUUUUUUUU...-5′, where the hairpin sequence is underlined), the dsRNA construct used in this study is identical to that employed in our preceding studies of Φ6 P2 RdRp ([@bib26], [@bib27]) ([Figure 1](#fig1){ref-type="fig"}A). This hairpin forms an efficient way to mimic a primer hybridized to the template strand and promotes primer-dependent initiation ([@bib1], [@bib2], [@bib3]).

Magnetic Tweezers Instrumentation {#sec4.2}
---------------------------------

The magnetic tweezers instrumentation employed here has been described previously ([@bib8], [@bib13], [@bib26], [@bib25]), with specifics of assays for detecting the activity of RdRps detailed in [@bib26]. The magnetic beads are each tethered to the flow chamber surface by a single dsRNA molecule. Hundreds of magnetic beads are tethered to a flow chamber surface by individual dsRNA molecules. The magnetic beads experience a constant force from a pair of permanent magnets placed above the flow chamber ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). This force is then transmitted directly to the RNA tether.

Reaction Conditions in the Magnetic Tweezers {#sec4.3}
--------------------------------------------

Once the RNA construct length is calibrated inside a flow cell containing PV RdRp reaction buffer (50 mM HEPES \[pH 7.9\], 5 mM MgCl~2~, 0.01% Triton X-100, and 5% Superase RNase inhibitor \[Life Technologies\]), 500 nM PV RdRp is flushed in. We perform experiments at 21°C for 1 hr at 30 pN applied force and fixed NTP concentration. We follow the (x, y, z) positions of up to 800 tethered magnetic beads in real time at 25 Hz ([@bib8], [@bib13], [@bib26]). Distinct traces are low-pass filtered at 0.5 Hz, providing an optical resolution of 0.3 nm along the optical axis (z axis) ([@bib13]), and aligned with respect to their starting position. The changes in extension are converted into the numbers of nucleotides transcribed using the known force-extension relationships for dsRNA and ssRNA molecules under the employed buffer conditions ([@bib26]).

To set up the stalling reaction with PV RdRp, we perform a 10-min incubation of PV RdRp with the dsRNA tethers in the flow cell in PV RdRp initiation buffer (PV RdRp reaction buffer supplemented with 1 mM rATP, 1 mM rGTP). We subsequently rinse the reaction chamber with an excess amount of PV RdRp reaction buffer containing 0.5% Superase RNase inhibitor (Life Technologies) in the absence of NTPs. We then trigger elongation by adding PV RdRp reaction buffer supplemented with NTPs and/or nucleotide analogs, as indicated.

Determination of Uncertainties in Measured and Fitted Parameter Values {#sec4.4}
----------------------------------------------------------------------

We compute a statistical error estimation for the median processivity (e.g., [Figure 2](#fig2){ref-type="fig"}A) by bootstrapping the median estimation 10,000 times and reporting the SD of the bootstrapped median estimation. The error bars provided for all log-binned histograms of the probability density distribution of the dwell times (e.g., [Figure 1](#fig1){ref-type="fig"}D) represent 1-SD confidence intervals extracted from 1,000 bootstraps of each indicated dwell-time distribution.

We calculate the errors in our fitted parameter estimates by bootstrapping ([@bib44]) each dataset 200 times, applying an MLE to these bootstrapped datasets, and determining the asymmetric one-sigma confidence intervals among the bootstrapped datasets. The fitted parameters are presented in the main text as either $\left( {value \pm X\%\ CI_{lower\ bound}^{upper\ bound}} \right)$, where $X\%\ CI$ indicates the range of the confidence interval, or $\left( {values \pm SD} \right)$.

PV-RdRp-Catalyzed Single-Nucleotide Incorporation Assays {#sec4.5}
--------------------------------------------------------

Reactions were performed as described in detail previously ([@bib2]). Briefly, elongation complexes were assembled by incubating 2 μM WT PV PVdRp with a 0.5 μM sym/sub RNA primer-template (1 μM duplex) for 3 min, at which time reactions were initiated with a 16 μM heparin trap and 100 μM NTP substrate. Reactions were quenched at various times by addition of 50 mM EDTA. All reactions were performed at 30°C in 50 mM HEPES (pH 7.5), 10 mM 2-mercaptoethanol and 5 mM MgCl~2.~ Products were analyzed by denaturing PAGE. Gels were visualized by using a Phosphor Imager and quantified by using ImageQuant TL software (GE Healthcare).

Inhibition of PV Replication by Ribavirin and T-1106 {#sec4.6}
----------------------------------------------------

HeLa cell monolayers in 6-well plates were pretreated for 1 hr with various concentrations of ribavirin and T-1106 and then infected with 50 plaque-forming units (PFUs) WT, H273R, or G64S PV, incubated for 20 min to allow for virus adsorption, and then washed and overlaid with 0.5% agarose media containing the same concentration of ribavirin or T-1106. Plates were incubated for 3--4 days at 37°C before overlays were removed and monolayers were stained with crystal violet. Plaques were counted and compared to the untreated control dish. To determine the IC~50~ value, the percentage of plaques was plotted as a function of ribavirin concentration and fit to a sigmoidal dose response equation:$$Y = A + \left( {\left( {100 - A} \right)/\left( {1 + \left( \left. {{\left\lbrack \text{ribavirin} \right\rbrack/{\ \text{IC}_{50}}}\ } \right) \right)^{H}} \right)} \right),$$where $Y$ is the percentage of plaques relative to untreated cells, $A$ is the minimum percentage of plaques, and $H$ is the Hill slope.

Cytotoxicity Assays {#sec4.7}
-------------------

HeLa cell monolayers in 24-well plates were treated with various concentrations of ribavirin and T-1106 for 7 hr. Cells were then washed, media without drug was added, and cells allowed to grow for 24 hr. Cells were detached using trypsin, counted, and compared to untreated control cells to determine the CC~50~ value.
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